Delivery Order SPE2DB20D3104-SPE2DB22FV6V1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The contract has a ceiling value of $5,517.17 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,355.23 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The $8,802.20 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical products to military and veterans' healthcare programs. The award is not designated under any set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,919.01 Firm Fixed Price Delivery Order is for the supply of 4,563,417,456 units of Monovisc 88 mg/4 ml syringes. The contract has an ultimate completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $8,302.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This appears to be a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6HXC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,538.74 firm fixed-price delivery order is for the supply of 4,563,906,717 units of the pharmaceutical product "MONOVISC 88 MG/4 ML SYRINGE 4ML." The contract has a period of performance through March 11, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $7,025.75 for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,485.78 firm fixed-price delivery order is for the provision of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,711.64 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that enables Amerisourcebergen Drug Corp to provide a comprehensive range...
- This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8HY1, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,766.01 firm-fixed-price delivery order is for the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of February 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV6V1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $3,937.10 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 5/10/22 |